Search

Your search keyword '"Honnen, William"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Honnen, William" Remove constraint Author: "Honnen, William"
49 results on '"Honnen, William"'

Search Results

4. Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes.

5. A novel sensitive immunoassay targeting the MTX-Lipoarabinomannan epitope meets the WHO's performance target for Tuberculosis diagnosis

6. A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.

9. Robust IgM responses following intravenous vaccination with Bacille Calmette–Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques

10. Author Correction: Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes

11. Detection of lipoarabinomannan in urine and serum of HIV-positive and HIV-negative TB suspects using an improved capture-enzyme linked immuno absorbent assay and gas chromatography/mass spectrometry

12. Broad-Spectrum Heavily Mutated Monoclonal Antibody Isolated from COVID-19 Convalescent Vaccinee with Capacity to Neutralize SARS-CoV2 Variants Ranging from B.1 to BQ.1.1

13. Vaccination of solid organ transplant recipients previously infected with SARS-CoV2 induces potent responses that extend to variants, including Omicron

14. Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccination

15. Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study

16. Phosphatidylserine-Targeting Monoclonal Antibodies Exhibit Distinct Biochemical and Cellular Effects on Anti-CD3/CD28–Stimulated T Cell IFN-γ and TNF-α Production

17. Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection

18. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry

19. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms

20. Robust IgM responses following vaccination are associated with prevention of Mycobacterium tuberculosis infection in macaques

21. Robust IgM responses following vaccination are associated with prevention of Mycobacterium tuberculosis infection in macaques

22. Natural infection with SARS-CoV-2 generates durable Spike S1 Receptor-Binding-Domain-specific memory B cell and neutralizing antibody responses.

23. Erratum: Author Correction: Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes (Scientific reports (2020) 10 1 (13944))

24. Vaccination boosts protective responses and counters SARS-CoV-2-induced pathogenic memory B cells

25. Robust IgM responses following intravenous vaccination with Bacille Calmette–Guérin associate with prevention of Mycobacterium tuberculosisinfection in macaques

26. Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid of Mycobacterium tuberculosis, and Complexity of Antibody Specificities toward This Antigen

28. Specific sequences commonly found in the V3 domain of HIV-1 subtype C isolates affect the overall conformation of native Env and induce a neutralization-resistant phenotype independent of V1/V2 masking

30. Characterization of Structural Features and Diversity of Variable-Region Determinants of Related Quaternary Epitopes Recognized by Human and Rhesus Macaque Monoclonal Antibodies Possessing Unusually Potent Neutralizing Activities

31. Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop

34. Antibodies That Are Cross-Reactive for Human Immunodeficiency Virus Type 1 Clade A and Clade B V3 Domains Are Common in Patient Sera from Cameroon, but Their Neutralization Activity Is Usually Restricted by Epitope Masking

36. Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades

41. Natural infection with SARS-CoV-2 generates durable Spike S1 Receptor-Binding-Domain-specific memory B cell and neutralizing antibody responses

47. Brilacidin, a Non-Peptide Defensin-Mimetic Molecule, Inhibits SARS-CoV-2 Infection by Blocking Viral Entry.

48. Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection.

49. Vaccination boosts protective responses and counters SARS-CoV-2-induced pathogenic memory B cells.

Catalog

Books, media, physical & digital resources